Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients
Clinical trial NCT04503668 · TERMINATED
Trial details
- NCT number
- NCT04503668
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-28
- Primary completion
- 2024-01-03
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.